Insider · CIK 0001938861

Cook Meredith

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001938861

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-14	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$70.79	−$35.4K	73,924
2026-08-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$75.48	−$37.7K	74,424
2026-07-18	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−2,466 sh	$79.20	−$195K	74,924
2026-07-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$81.84	−$40.9K	77,390
2026-06-12	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$82.03	−$41K	77,890
2026-05-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$78.16	−$39.1K	78,390
2026-04-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$77.95	−$39K	78,890
2026-03-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$72.62	−$36.3K	79,390
2026-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,555 sh	$73.90	−$115K	79,890
2026-02-26	ANIPANI PHARMACEUTICALS INCA Award	SR. VP, GENERAL COUNSEL & SEC.	AAward	+13.9K sh	$77.15	+$1.07M	81,445
2026-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,779 sh	$77.36	−$138K	67,550
2026-02-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$76.80	−$38.4K	69,329
2026-02-12	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,534 sh	$76.70	−$118K	69,829
2026-02-11	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−3,011 sh	$76.25	−$230K	71,363
2026-01-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−500 sh	$84.33	−$42.2K	74,374
2025-12-12	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$82.32	−$32.9K	74,874
2025-11-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$87.27	−$34.9K	75,274
2025-10-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$90.09	−$36K	75,674
2025-09-12	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$98.42	−$39.4K	76,074
2025-08-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$88.87	−$35.5K	76,474
2025-07-18	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−2,071 sh	$66.30	−$137K	76,874
2025-07-14	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$64.88	−$26K	78,945
2025-06-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$61.37	−$24.5K	79,345
2025-05-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$62.20	−$24.9K	79,745
2025-04-14	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$68.96	−$27.6K	80,145
2025-03-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$63.33	−$25.3K	80,545
2025-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,099 sh	$61.89	−$68K	80,945
2025-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,434 sh	$58.92	−$84.5K	82,044
2025-02-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$59.54	−$23.8K	83,478
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	SR. VP, GENERAL COUNSEL & SEC.	AAward	+11.3K sh	—	—	83,878
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	SR. VP, GENERAL COUNSEL & SEC.	AAward	+17K sh	—	—	72,562
2025-01-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−400 sh	$53.92	−$21.6K	55,588
2024-12-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$56.24	−$14.1K	55,988
2024-11-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$61.36	−$15.3K	56,238
2024-10-14	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$57.19	−$14.3K	56,488
2024-09-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$56.82	−$14.2K	56,738
2024-08-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$59.62	−$14.9K	56,988
2024-07-18	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,743 sh	$61.35	−$107K	57,238
2024-07-12	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$64.91	−$16.2K	58,981
2024-06-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$63.80	−$16K	59,231
2024-05-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$67.69	−$16.9K	59,481
2024-04-12	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$67.79	−$16.9K	59,731
2024-03-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$66.54	−$16.6K	59,981
2024-02-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	SR. VP, GENERAL COUNSEL & SEC.	FTax Payment	−1,173 sh	$67.67	−$79.4K	60,231
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SR. VP, GENERAL COUNSEL & SEC.	AAward	+14.8K sh	—	—	51,562
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SR. VP, GENERAL COUNSEL & SEC.	AAward	+9,842 sh	—	—	61,404
2024-02-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$56.04	−$14K	36,799
2024-01-12	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$56.43	−$14.1K	37,049
2023-12-11	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$49.21	−$12.3K	37,299
2023-11-13	ANIPANI PHARMACEUTICALS INCS Sale	SR. VP, GENERAL COUNSEL & SEC.	SSale	−250 sh	$52.03	−$13K	37,549

Recent filings

Accepted (ET)
Sep 144
Cook Meredith0001938861-26-000026
SEC(opens sec.gov)
Aug 134
Cook Meredith0001938861-26-000023
SEC(opens sec.gov)
Jul 214
Cook Meredith0001938861-26-000021
SEC(opens sec.gov)
Jul 144
Cook Meredith0001938861-26-000019
SEC(opens sec.gov)
Jun 154
Cook Meredith0001938861-26-000017
SEC(opens sec.gov)
May 134
Cook Meredith0001938861-26-000015
SEC(opens sec.gov)
Apr 134
Cook Meredith0001938861-26-000013
SEC(opens sec.gov)
Mar 134
Cook Meredith0001938861-26-000010
SEC(opens sec.gov)
Mar 24
Cook Meredith0001938861-26-000008
SEC(opens sec.gov)
Feb 174
Cook Meredith0001938861-26-000006
SEC(opens sec.gov)
Feb 134
Cook Meredith0001938861-26-000004
SEC(opens sec.gov)
Jan 144
Cook Meredith0001938861-26-000002
SEC(opens sec.gov)
Dec 124
Cook Meredith0001938861-25-000030
SEC(opens sec.gov)
Nov 144
Cook Meredith0001938861-25-000028
SEC(opens sec.gov)
Oct 144
Cook Meredith0001938861-25-000026
SEC(opens sec.gov)
Sep 154
Cook Meredith0001938861-25-000024
SEC(opens sec.gov)
Aug 144
Cook Meredith0001938861-25-000020
SEC(opens sec.gov)

Companies

ANI PHARMACEUTICALS INCSR. VP, GENERAL COUNSEL & SEC.ANIP

Address

C/O ANI PHARMACEUTICALS, INC. 104 CARNEGIE CENTER, SUITE 300

PRINCETON, NJ, 08540